◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksO › OMDA

Omada Health, Inc. Common Stock (OMDA) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-09-16

Omada Health, Inc. Common Stock (OMDA) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in South San Francisco, United States with about 946 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, OMDA reported $260M in revenue and ($13M) in net income.

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.

Interactive charts & full statements → Open the OMDA valuation workbench →

OMDA Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-31
Total Revenue$310M$260M$170M$123M$89M
Gross Profit$211M$171M$103M$70M$43M
Gross Margin %68.2%65.7%60.6%57.0%48.0%
Operating Income (EBIT)$0M($12M)($44M)($66M)($72M)
Operating Margin %-0.1%-4.6%-25.7%-53.8%-81.1%
Net Income$4M($13M)($47M)($68M)($73M)
Net Margin %1.4%-4.9%-27.8%-55.0%-81.3%
EBITDA$12M($5M)($38M)($58M)($64M)
Earnings Per Share (EPS)$0.07$-0.22$-0.85$-1.21$-1.30
Shares Outstanding (M)64M58M56M56M56M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMDA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$88M$78M$76M$68M$61M$55M$48M$46M
Gross Profit$64M$49M$54M$45M$40M$32M$32M$28M
Gross Margin %72.6%62.4%70.8%66.2%65.5%58.0%66.6%62.4%
Operating Income (EBIT)$4M($5M)$3M($3M)($4M)($8M)($7M)($9M)
Operating Margin %4.0%-6.1%4.3%-3.7%-7.1%-15.3%-14.8%-18.7%
Net Income$5M($3M)$5M($3M)($5M)($9M)($8M)($9M)
Net Margin %6.0%-3.8%6.8%-4.7%-8.6%-17.2%-17.2%-20.3%
EBITDA$8M($1M)$7M($2M)($3M)($7M)($6M)($7M)
Earnings Per Share (EPS)$0.08$-0.05$0.09$-0.06$-0.09$-0.17$-0.15$-0.17
Shares Outstanding (M)64M59M58M58M57M56M56M56M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMDA Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-31
Cash from Operations (CFO)$24M$18M($34M)($50M)($69M)
Capital Expenditures (CapEx)$4M$1M$4M$3M$3M
Free Cash Flow (FCF)$20M$17M($38M)($53M)($72M)
FCF Margin %6.5%6.5%-22.4%-42.9%-80.4%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMDA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$4M($12M)$21M$10M$3M($16M)($6M)$1M
Capital Expenditures (CapEx)$1M$0M$0M$2M$1M$1M$1M$1M
Free Cash Flow (FCF)$3M($12M)$21M$8M$2M($17M)($7M)$0M
FCF Margin %3.0%-15.3%27.9%12.0%2.6%-31.6%-15.5%-0.0%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OMDA Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-31
Total Assets$328M$305M$151M$175M$222M
Cash & Cash Equivalents$222M$222M$76M$116M$168M
Total Liabilities$75M$76M$86M$76M$66M
Total Debt (Short + Long-Term)$0M$0M$30M$30M$30M
Total Shareholders' Equity$253M$230M$65M$99M$156M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OMDA viewer.

Other Companies in HEALTH INFORMATION SERVICES

← OMCLAll “O” companiesOMER →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.